Patents by Inventor Pingju GE

Pingju GE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODIES BINDING TO SARS-COV-2 VIRUS AND USES THEREOF
    Publication number: 20240124558
    Abstract: The embodiments of the present disclosure provide an antibody or antigen-binding fragment against SARS-CoV-2 spike(S) protein, comprising: three complementarity determining regions (HCDRs) of a heavy chain variable region or one or more variants thereof, the heavy chain variable region set forth as SEQ ID NO. 30 or SEQ ID NO. 46, each of the one or more variants having at most two amino acid changes compared to the corresponding CDR; and three complementarity determining regions (LCDRs) of a light chain variable region or one or more variants thereof, the light chain variable region set forth as SEQ ID NO. 32 or SEQ ID NO. 48, each of the one or more variants having at most two amino acid changes compared to the corresponding CDR.
    Type: Application
    Filed: December 20, 2023
    Publication date: April 18, 2024
    Applicant: ASSURE TECH. (HANGZHOU) CO., LTD.
    Inventors: Yiding CHEN, Xiangxi WANG, Ling ZHU, Yinan JIANG, Jingyun MIAO, Lili QIN, Pingju GE
  • ANTI-B7-H3 ANTIBODIES
    Publication number: 20220235134
    Abstract: Provided are antibodies that specifically recognize B7 homology 3 protein (B7-H3).
    Type: Application
    Filed: May 27, 2020
    Publication date: July 28, 2022
    Applicants: Single Cell Technology, Inc., ACROBiosystems, Inc.
    Inventors: Leyan TANG, Allison SCHULKINS, Kimberly THAN, Chun-Nan CHEN, Jingyun MIAO, Xiaohui ZHANG, Xiaojuan SHI, Lin ZHANG, Pingju GE